Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

KYG5140V1207
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG012Q6SBJ7
ZJYL

Jin Medical International Ltd.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Medical Instruments & Supplies
NAME
Jin Medical International Ltd.
ISIN
KYG5140V1207
TICKER
ZJYL
MIC
XNAS
REUTERS
ZJYL.OQ
BLOOMBERG
ZJYL US
Tue, 04.08.2026       Jin Medical

CHANGZHOU, China, Aug. 4, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, today announced its unaudited financial results for the six months ended March...
Tue, 07.04.2026       Jin Medical

CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has received written notification from the Nasdaq Listing Quali...
Thu, 12.03.2026       Jin Medical

CHANGZHOU, China, March 11, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that its Board of Directors has approved an 1-for-20 share combination...